作者:José Martínez-Lillo、Teresa F. Mastropietro、Rosamaria Lappano、Antonio Madeo、Marta E. Alberto、Nino Russo、Marcello Maggiolini、Giovanni De Munno
DOI:10.1039/c1cc11038a
日期:——
The anticancer properties of a series of mononuclear Re(IV) compounds of formula ReCl(4)L (where L is bpy = 2,2'-bipyridine; bpym = 2,2'-bipyrimidine; dmbpy = 4,4'-dimethyl-2,2'-bipyridine; phen = 1,10-phenanthroline) were investigated for the first time. All compounds displayed potent in vitro antiproliferative activity against selected cancer cells.
一系列式ReCl(4)L的单核Re(IV)化合物的抗癌特性(其中L是bpy = 2,2'-联吡啶; bpym = 2,2'-联嘧啶; dmbpy = 4,4'-二甲基-2,2'-联吡啶; phen = 1,10-菲咯啉)为首次研究。所有化合物均对选定的癌细胞显示出有效的体外抗增殖活性。